Jon Hamilton

A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.

A national survey of people who care for someone with dementia found that the vast majority could use help navigating a maze of services.

The first drug found to slow the progression of Alzheimer’s disease has been granted full approval by the Food and Drug Administration.

The Food and Drug Administration may soon grant full approval to an Alzheimer’s drug. When it does, Medicare will start more widely covering the costly drug — but hurdles to access remain.

The Food and Drug Administration is expected to grant full approval to the Alzheimer’s drug lecanemab by July 6. But access to the drug may still be limited.

Despite a high risk of brain injuries, military personnel rarely develop a disabling brain condition often found in former boxers and football players.

Intensive rehabilitative therapy that starts two to three months after a stroke may be key to helping the injured brain rewire, a new study suggests. That’s later than covered by many insurance plans.

Surveys show that support for COVID-19 vaccines is rising among Black and Latinx populations, now that tens of millions of Americans have safely received the shots.

Nonwhite Americans looking for care for a loved one are much more likely than whites to encounter discrimination, language barriers, and providers who lack cultural competence, a new report finds.

People who get more deep sleep appear less likely to develop Alzheimer’s. That may be because this phase of sleep allows the brain clears out waste products.